> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Allergan NDA Lo Minastrin FE Withdrawn
- URL: https://www.fdaweb.com/allergan-nda-lo-minastrin-fe-withdrawn/
- Published: 2019-10-25T12:00:00.000Z
- Updated: 2026-09-15T01:59:01.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145339

Federal Register notice: FDA is withdrawing the NDA approval of Allergan Pharmaceuticals’ Lo Minastrin FE (ethinyl estradiol tablets, 0.01 mg; ethinyl estradiol and norethindrone acetate tablets, 0.01 mg/1mg; and ferrous fumarate tablets, 75 mg). Allergan notified the agency that the drug product was no longer marketed and requested that it be withdrawn. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-10-25/pdf/2019-23309.pdf?ref=fdaweb.com).